RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $791M
1-Year Est. Return 12.81%
This Quarter Est. Return
1 Year Est. Return
+12.81%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$696M
AUM Growth
+$65M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$21M
2
+$13.8M
3
+$10.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$7.96M
5
SNY icon
Sanofi
SNY
+$7.67M

Top Sells

1
+$11.2M
2
+$10.8M
3
+$8.62M
4
ESPR icon
Esperion Therapeutics
ESPR
+$8.33M
5
BIIB icon
Biogen
BIIB
+$5.29M

Sector Composition

1 Healthcare 92.59%
2 Financials 0.93%
3 Technology 0.13%
4 Energy 0.1%
5 Consumer Discretionary 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$2.21M 0.32%
+35,573
77
$2.18M 0.31%
400,000
78
$2.14M 0.31%
15,000
79
$1.86M 0.27%
31,000
80
$1.8M 0.26%
35,000
81
$1.54M 0.22%
120,000
-50,000
82
$1.29M 0.19%
30,000
-200,000
83
$1.03M 0.15%
+17,500
84
$837K 0.12%
30,000
-60,000
85
$762K 0.11%
166,000
86
$755K 0.11%
69,950
+41,239
87
$744K 0.11%
+5,226
88
$585K 0.08%
4,947
89
$442K 0.06%
4,837
90
$441K 0.06%
5,179
91
$420K 0.06%
30,099
92
$405K 0.06%
7,305
93
$389K 0.06%
4,823
94
$385K 0.06%
15,401
95
$371K 0.05%
40,000
96
$364K 0.05%
3,008
-26,992
97
$348K 0.05%
120,000
98
$330K 0.05%
7,718
99
$330K 0.05%
4,793
100
$318K 0.05%
28,404
+5,893
1 2 3
4
5